Rizzoli R., Forni M., Schaad M.A., Slosman D.O., Sappino A.P., Garcia J., Bonjour
J.P.
Effects of oral clodronate on bone mineral density in patients with relapsing breast
cancer // Bone. — 1996. — V.18(6). — P. 531 537.
Robertson R.B., Baylink D.J., Metz S.A., Cummings K.B.
Plasma prostaglandin E in
patients with cancer with and without hypercalcaemia // J. Clin. Endocrinol. Metab. —
1976. — V. 43. — P. 1330 1335.
Robertson A.G., Reed N.S., Ralston S.H.
Effect of oral clodronate on metastatic bone
pain: A double blind, placebo controlled study // J. Clin. Oncol. — 1995. — V. 13. —
P. 2427 2430.
Robinson R., Spicer J.A., Preston D.F., Wegst A.V., Martin N.L.
Treatment of
metastatic bone pain with strontium 89 // Nucl. Med. Biol. — 1987. — V. 14. — P. 219
222.
Robinson R.G., Preston D.F, Schiefelbein M
. Srtontium 89 therapy for the palliation
of pain due to osseous metastases // J.A.M.A. — 1995. — V. 274. — P. 420 424.
Robustelli Della Cuna G.
Progestins // In: Handbook of Chemotherapy in Clinical
Oncology/ Eds. E. Cvitkovic è ñîàâò., 2nd ed. Scientific Commun. International Ltd. —
1993. — P. 371 375.
Rochefort H.
Cathepsin D in breast cancer: a tissue marker associated with metasta
sis // Eur. J. Cancer. — 1992. — V. 28A. — P. 1780 1783.
Rodan G., Insogna K.L., Vignery A.
è ñîàâò. Factors associated with humoral hyper
calcaemia of malignancy stimulate adenylate cyclase in osteoblastic cells // J. Clin. Invest. —
1983. — V. 72 — P. 1151 1515.
Rodan G.
Interleukin 6: an osteotropic cytocine // J. Bone Min. Res. — 1992. —
V. 7. — P. 475 478.
Roodman D.
// Endocrine Rev. — 1996. — V. 17. — P. 308 332.
Rosenthal D.I.
Radiologic diagnosis of bone metastases // Cancer. — 1997. —
V. 80(Suppl. 8). — P. 1595 1607.
Rossleigh M.A., Lovegrove F.T.A., Reynolds P.M., Byrne M.J., Whitney B.P.
The
assessment of reasponse to therapy of bone metastases in breast cancer // Aust. N.Z. J.
Med. — 1984. — V.14. — P. 19 22.
Rotstein S., Glas U., Eriksson M.
è ñîàâò. Intravenous clodronate for the treatment
of hypercalcaemia in breast cancer patients with bone metastases A prospective ran
domised placebo controlled multicentre study // Eur. J. Cancer. — 1992. — V. 28A. —
P. 890 893.
Rubens R.D., Tinson C.L., Coleman R.E.
è ñîàâò. Prednisolone improves the
response to primary endocrine thretment for advanced breast cancer // Br. J. Cancer. —
1988. — V. 55. — P. 626 630.
Rubens R.D., Fogelman J.
Bone metastases // London: Springer. — 1991. — 260 p.
Saarto T., Blomqvist C., Pekka V., Virkkunen P., Elooma
No reduction on bone
metastasis with adjuvant clodronate treatment in node positive breast cancer patients //
Proc. Annu. Meet. Am. Soc. Clin. Oncol. — 1999. — V. 19. — P. 128.
Sabo D., Bernd L.
Surgical management of skeletal metastases of the extremities //
Orthopade. — 1998. — V. 27(5). — P. 274 281.
Sacks P.
Prolactin, prostaglandin and bone pain of metastatic breast cancer //
Lancet. — 1974. — V. 11. —¹ 7893. — P.13.
Salazar O.M., Rubin P., Hendrickson F.R.
è ñîàâò. Single dose half body irradiation
for the palliation of multiple bone metastases from solid tumors // Preliminary report. Int.
J. Rad. Oncol. Biol. Phys. — 1981. — V. 7/6. — P.773 781.
245
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
